Yidu Tech’s AI Agents Now Handle 20% of Hospital Tasks: Human-Machine Collaboration Model Showcased at Summer Davos
TIANJIN, China, June 27, 2025 /PRNewswire/ -- From June 24 to 26, the World Economic Forum 2025 Annual Meeting of the New Champions (the 16th Summer Davos Forum) was held in Tianjin. Artificial intelligence, as the new frontier of global economic growth, was one of the hottest topics of this year's forum. Dialogue on the Theme of "AI+ Era"...
Vinamilk Showcases Science-Driven Innovation and Wins Prestigious Awards at Global Dairy Congress 2025
AMSTERDAM, June 27, 2025 /PRNewswire/ -- Vinamilk, Vietnam's leading dairy company, presented its science-driven innovation strategy at the Global Dairy Congress (GDC) 2025 and was honoured with two prestigious accolades at the 2025 World Dairy Innovation Awards. A Highlight of Science-Based Nutrition at GDC-18 Held in Amsterdam, Netherlands, 18th Global Dairy Congress brought together nearly 200...
MGI ANNOUNCES PARTNERSHIP WITH NEGEDIA: ENHANCE GENOMIC SEQUENCING TECHNOLOGIES AT THE SERVICE OF SCIENTIFIC RESEARCH AND PRECISION MEDICINE IN ITALY
In the study of rare diseases and precision medicine, understanding gene expression in the spatial context of tissues is essential. High-throughput sequencing and STOmics technology will enhance biological and molecular understanding of various pathologies. MILAN, June 27, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools...
WuXi AppTec Nantong Site Receives 2025 Architizer A+Award for Its Unique Blend of Technology and Humanity
SHANGHAI, June 27, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, is delighted to announce that its Nantong site (Phase I) has been recognized as the Popular Choice Winner in the "Factory & Warehouse" category at the 2025 Architizer A+Awards. This...
Origin Agritech Announced Financial Results for the Six Months Ended March 31, 2025
BEIJING, June 27, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced financial results for the six months ended March 31, 2025. Business Accomplishments and Highlights for the Six Months Ended March 31, 2025, and to date: Strategic Partnerships and Commercialization: In October 2024, Origin established the...
NEW SINGAPORE STUDY TO ASSESS GROWING PREVALENCE AND IMPACT OF FOOD ALLERGIES
Landmark four-year joint study led by NUH and NUS Medicine, in collaboration with KKH, NUP and SSHSPH, is the first and largest to involve over 2,000 children in addressing food allergies SINGAPORE, June 26, 2025 /PRNewswire/ -- A group of clinicians and researchers from the National University Hospital (NUH), Yong Loo...
Invetech and AiCella Announce Strategic Collaboration to Advance Cell Therapy Innovation
SAN DIEGO, June 27, 2025 /PRNewswire/ -- Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today announced a strategic collaboration with AiCella, a company focused on harnessing the power of artificial intelligence (AI) to optimize the development of cell therapy...
SineuGene’s SNUG01 Receives FDA Orphan Drug Designation for ALS
BEIJING, June 26, 2025 /PRNewswire/ -- SineuGene Therapeutics, a clinical-stage biotechnology company focused on gene therapies for neurological diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its gene therapy, SNUG01, for the treatment of amyotrophic lateral sclerosis (ALS). SNUG01 is a first-in-class gene therapy targeting TRIM72 (Tripartite Motif Containing 72),...
Porton Advanced and EVA Pharma Sign MOU to Expand CAR T-Cell Therapy Access in The Middle East and Africa
A new era of personalized gene therapy for Leukemia patients in Egypt, Saudi Arabia, and beyond. SUZHOU, China and CAIRO, June 26, 2025 /PRNewswire/ -- Porton Advanced Solutions, a global leading cell and gene therapy CDMO service provider, and EVA Pharma, one of the leading pharmaceutical companies driving healthcare innovation and access across the Middle East and Africa, have...
Ubie Announces Cumulative Total Funding of Over $125M as US Efforts Target Expansion into Generative AI and Provider Solutions
Ubie's growth has been accelerated by recent strategic investment and acceptance into Mayo Clinic Platform Accelerate program Ubie's US Symptom Checker platform has seen 85% organic growth and a total user base of 4 million, helping deliver partnerships across patient advocacy and life sciences NEW YORK, June 26, 2025...
